These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15503716)

  • 1. Sonographic markers used to detect frequent trisomies.
    Oyler M; Long BW; Cox LA
    Radiol Technol; 2004; 76(1):13-8. PubMed ID: 15503716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis by rapid aneuploidy detection and karyotyping: a prospective study of the role of ultrasound in 1589 second-trimester amniocenteses.
    Leung WC; Waters JJ; Chitty L
    Prenat Diagn; 2004 Oct; 24(10):790-5. PubMed ID: 15503279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal sonographic findings in trisomy 13, 18, 21 and 22. A review of 46 cases.
    Seoud MA; Alley DC; Smith DL; Levy DL
    J Reprod Med; 1994 Oct; 39(10):781-7. PubMed ID: 7837124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Trisomy 18 based on serum screening.
    Cho RC; Chu P; Smith-Bindman R
    Prenat Diagn; 2009 Feb; 29(2):129-39. PubMed ID: 19142904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of gestational age on the sonographic detection of aneuploidy.
    Picklesimer AH; Moise KJ; Wolfe HM
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1243-7. PubMed ID: 16157145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic markers of fetal trisomies: second trimester.
    Nyberg DA; Souter VL
    J Ultrasound Med; 2001 Jun; 20(6):655-74. PubMed ID: 11400940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K; Crossley JA; Aitken DA; Nicolaides KH
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of prenatal ultrasound diagnosis and pathologic findings in fetuses with trisomy 13.
    Szigeti Z; Csapó Z; Joó JG; Pete B; Papp Z; Papp C
    Prenat Diagn; 2006 Dec; 26(13):1262-6. PubMed ID: 17099926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The placenta and trisomies 13, 18, 21].
    Labbé S; Copin H; Choiset A; Girard S; Barbet JP
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(8):989-96. PubMed ID: 2533599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is second-trimester genetic amniocentesis for trisomy 18 ever indicated in the presence of a normal genetic sonogram?
    Oyelese Y; Vintzileos AM
    Ultrasound Obstet Gynecol; 2005 Dec; 26(7):691-4. PubMed ID: 16308891
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
    Donaghue C; Mann K; Docherty Z; Ogilvie CM
    Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester tests for trisomies 21 and 18 as sensitive as triple screen.
    Lewis PR; Pasalio R
    J Fam Pract; 2004 Mar; 53(3):184-6. PubMed ID: 15000919
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of sonographic markers of fetal aneuploidy depends on maternal and fetal characteristics.
    Taslimi MM; Acosta R; Chueh J; Hudgins L; Hunter K; Druzin ML; Chitkara U
    J Ultrasound Med; 2005 Jun; 24(6):811-5. PubMed ID: 15914685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13.
    Ki KD; Kim SR; Lee WI
    Fetal Diagn Ther; 2009; 26(1):54-6. PubMed ID: 19816033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sonographic detection of trisomies 13, 18, and 21.
    Hill LM
    Clin Obstet Gynecol; 1996 Dec; 39(4):831-50. PubMed ID: 8934034
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
    Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of complete trisomy 9: a case report and review of the literature.
    Kor-Anantakul O; Suwanrath C; Kanngurn S; Rujirabanjerd S; Suntharasaj T; Pinjaroen S
    Am J Perinatol; 2006 Feb; 23(2):131-5. PubMed ID: 16506121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.